Artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis

<div>Short-term (28/90 days) survival curves for patients with HBV-ACLF. (a) 28-day survival curves for patients in the SMT and ALSS groups. (b) 90-day survival curves for patients in the SMT and ALSS groups. HBV-ACLF, hepatitis B virus-related acute-on-chronic liver failure; STM, standard medical therapy; ALSS, artificial liver support system.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis 

Figure 2 | Artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis 